- $4.08bn
- $3.60bn
- $1.66bn
- 97
- 72
- 49
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,171 | 1,039 | 1,174 | 1,112 | 1,663 |
Cost of Revenue | |||||
Gross Profit | 991 | 860 | 976 | 894 | 1,410 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,346 | 1,151 | 1,206 | 1,118 | 1,249 |
Operating Profit | -175 | -112 | -32.3 | -6.09 | 414 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -197 | -96.5 | -39.3 | -31.1 | 422 |
Provision for Income Taxes | |||||
Net Income After Taxes | -197 | -111 | -48.2 | -33.2 | 519 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -197 | -111 | -48.2 | -158 | 356 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -197 | -111 | -48.2 | -158 | 356 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.2 | -0.698 | -0.287 | -0.2 | 3.09 |